By supporting SysChem and its research school, you are contributing to the training of young chemists at a very high level .
Health is also a key area of SysChem’s research.
Investing in the development of innovative biomedical technologies constitutes a strong commitment to the future health of our populations.
Chemistry is a key discipline at the University of Strasbourg, which is the leading university in the field in France and the European Union.
Partnering with SysChem means supporting the flagship of French research and becoming a local stakeholder committed to the preservation of a national asset.
In 2021, with a contribution of €480,000, the region co-financed doctoral bursaries at the CSC Graduate School.
This strategic funding helped to attract international talents, managers and creatives, ready to respond to society’s greatest future challenges in the bank’s preferred fields of the environment and health.
AXA Research Fund has a mission to support research aimed at solving very concrete issues, particularly in the domain of health.
In 2009, AXA made a capital endowment donation of €2.25m to establish a chair in supramolecular chemistry in Strasbourg.
As a capital endowment, it meant that Luisa De Cola, the renowned researcher specially recruited for the creation of the chair, had permanent resources at her disposal to conduct her research.
The researcher developed nano-containers capable of transporting drugs, DNA or enzymes to the target diseased cells, an alternative to classic chemotherapy that also raised the hope of new treatments for age-related illnesses.
Luisa De Cola has brilliantly demonstrated her effectiveness at producing results in research applied to medicine: since 2013, her laboratory has published 90 articles, filed 32 patents and created a start-up!